Showing results (61-70 of 72) with videos related to
Sort By:
Pageof 8
Molecular Medicine (Cambridge, Mass.)|December 10, 1997
Characterization of new polyclonal antibodies specific for 40 and 42 amino acid-long amyloid beta peptides: their use to examine the cell biology of presenilins and the immunohistochemistry of sporadic Alzheimer's disease and cerebral amyloid angiopathy casesH Barelli, A Lebeau, J Vizzavona, et al.Translational Psychiatry|July 27, 2012
Increased expression of receptor phosphotyrosine phosphatase-β/ζ is associated with molecular, cellular, behavioral and cognitive schizophrenia phenotypesN Takahashi, T Sakurai, O Bozdagi-Gunal, et al.Journal of Autism and Developmental Disorders|February 8, 2017
Examining the Efficacy of a Family Peer Advocate Model for Black and Hispanic Caregivers of Children with Autism Spectrum DisorderJ M Jamison, E Fourie, P M Siper, et al.The American Journal of Pathology|September 1, 1996
Novel neuritic clusters with accumulations of amyloid precursor protein and amyloid precursor-like protein 2 immunoreactivity in brain regions damaged by thiamine deficiencyN Y Calingasan, S E Gandy, H Baker, et al.Molecular Psychiatry|March 2, 2011
Rare structural variation of synapse and neurotransmission genes in autismX Gai, H M Xie, J C Perin, et al.European Journal of Pharmacology|April 20, 2000
Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy body diseasesE Perry, C Martin-Ruiz, M Lee, et al.Molecular Psychiatry|June 21, 2007
Molecular dissection of NRG1-ERBB4 signaling implicates PTPRZ1 as a potential schizophrenia susceptibility geneJ D Buxbaum, L Georgieva, J J Young, et al.Nature Medicine|April 18, 1998
Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptidesH Xu, G K Gouras, J P Greenfield, et al.Molecular Psychiatry|April 30, 2009
High-density SNP association study and copy number variation analysis of the AUTS1 and AUTS5 loci implicate the IMMP2L-DOCK4 gene region in autism susceptibilityE Maestrini, A T Pagnamenta, J A Lamb, et al.Molecular Psychiatry|August 2, 2012
Latrepirdine improves cognition and arrests progression of neuropathology in an Alzheimer's mouse modelJ W Steele, M L Lachenmayer, S Ju, et al.Pageof 8